377 related articles for article (PubMed ID: 10518221)
1. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.
Gerety SS; Wang HU; Chen ZF; Anderson DJ
Mol Cell; 1999 Sep; 4(3):403-14. PubMed ID: 10518221
[TBL] [Abstract][Full Text] [Related]
2. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.
Adams RH; Wilkinson GA; Weiss C; Diella F; Gale NW; Deutsch U; Risau W; Klein R
Genes Dev; 1999 Feb; 13(3):295-306. PubMed ID: 9990854
[TBL] [Abstract][Full Text] [Related]
3. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.
Wang HU; Chen ZF; Anderson DJ
Cell; 1998 May; 93(5):741-53. PubMed ID: 9630219
[TBL] [Abstract][Full Text] [Related]
4. Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells.
Zhang XQ; Takakura N; Oike Y; Inada T; Gale NW; Yancopoulos GD; Suda T
Blood; 2001 Aug; 98(4):1028-37. PubMed ID: 11493448
[TBL] [Abstract][Full Text] [Related]
5. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis.
Limbourg A; Ploom M; Elligsen D; Sörensen I; Ziegelhoeffer T; Gossler A; Drexler H; Limbourg FP
Circ Res; 2007 Feb; 100(3):363-71. PubMed ID: 17234965
[TBL] [Abstract][Full Text] [Related]
6. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
Helbling PM; Saulnier DM; Brändli AW
Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
[TBL] [Abstract][Full Text] [Related]
7. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
Cowan CA; Yokoyama N; Saxena A; Chumley MJ; Silvany RE; Baker LA; Srivastava D; Henkemeyer M
Dev Biol; 2004 Jul; 271(2):263-71. PubMed ID: 15223333
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
9. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells.
Oike Y; Ito Y; Hamada K; Zhang XQ; Miyata K; Arai F; Inada T; Araki K; Nakagata N; Takeya M; Kisanuki YY; Yanagisawa M; Gale NW; Suda T
Blood; 2002 Aug; 100(4):1326-33. PubMed ID: 12149214
[TBL] [Abstract][Full Text] [Related]
10. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
11. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
12. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
Pitulescu ME; Adams RH
Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
[TBL] [Abstract][Full Text] [Related]
13. Molecular identity of arteries, veins, and lymphatics.
Wolf K; Hu H; Isaji T; Dardik A
J Vasc Surg; 2019 Jan; 69(1):253-262. PubMed ID: 30154011
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
[TBL] [Abstract][Full Text] [Related]
15. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
17. Gridlock in the blood.
Thurston G; Yancopoulos GD
Nature; 2001 Nov; 414(6860):163-4. PubMed ID: 11700541
[No Abstract] [Full Text] [Related]
18. Temporally compartmentalized expression of ephrin-B2 during renal glomerular development.
Takahashi T; Takahashi K; Gerety S; Wang H; Anderson DJ; Daniel TO
J Am Soc Nephrol; 2001 Dec; 12(12):2673-2682. PubMed ID: 11729236
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis.
Gerety SS; Anderson DJ
Development; 2002 Mar; 129(6):1397-410. PubMed ID: 11880349
[TBL] [Abstract][Full Text] [Related]
20. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.
Takai N; Miyazaki T; Fujisawa K; Nasu K; Miyakawa I
Oncol Rep; 2001; 8(3):567-73. PubMed ID: 11295082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
